Human-derived monoclonal autoantibodies as interrogators of cellular proteotypes in the brain DOI Creative Commons
Matthew L. Baum, Christopher M. Bartley

Trends in Neurosciences, Год журнала: 2024, Номер unknown

Опубликована: Сен. 1, 2024

Язык: Английский

Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders DOI

Panrui Lu,

Y. Cheng, Lei Xue

и другие.

Cell, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

18

Smartphone-Manipulated Mild-Temperature Photothermal Control of the TfR-LYTAC Platform for Tumor Treatment DOI
Chengyong Shi,

Ling-Yan Su,

Wen Xu

и другие.

Nano Letters, Год журнала: 2025, Номер unknown

Опубликована: Март 12, 2025

A lysosome-targeting chimera (LYTAC) offers a novel strategy for degrading extracellular proteins previously considered to be undruggable by hijacking the lysosomal degradation system. However, clinical use of LYTAC has been limited due potential uncontrolled and systemic toxicity. Based on our developed genetically encoded TfR-LYTAC, here, we introduce photothermal-inducible switch in engineered bacterium enable spatiotemporal expression TfR-LYTAC. We also precise photothermal systems control via cellphone manipulation avoid burns normal tissues, especially skin, caused intense laser light. The exhibited significant tumor-suppressing effects upon exposure phone-manipulated both subcutaneously transplanted melanoma colon tumor models with no skin damage mice. Our approach enables precision medicine provides generalizable platform developing light-driven LYTAC. study outpatient or home treatment is further step telemedicine.

Язык: Английский

Процитировано

1

Compensation of gene dosage on the mammalian X DOI Creative Commons
Daniela Cecalev, Beatriz Viçoso, Rafael Galupa

и другие.

Development, Год журнала: 2024, Номер 151(15)

Опубликована: Авг. 1, 2024

Changes in gene dosage can have tremendous evolutionary potential (e.g. whole-genome duplications), but without compensatory mechanisms, they also lead to dysregulation and pathologies. Sex chromosomes are a paradigmatic example of naturally occurring differences their compensation. In species with chromosome-based sex determination, individuals within the same population necessarily show 'natural' for chromosomes. this Review, we focus on mammalian X chromosome discuss recent new insights into dosage-compensation mechanisms that evolved along emergence chromosomes, namely X-inactivation X-upregulation. We evolution genetic loci molecular players involved, as well regulatory diversity potentially different requirements compensation across species.

Язык: Английский

Процитировано

5

A TRIM21-based method for targeted protein degradation DOI Creative Commons
Weikang Hu, Xiang Qiu, Yun Yang

и другие.

Acta Biochimica et Biophysica Sinica, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

4

POT, an optogenetics-based endogenous protein degradation system DOI Creative Commons

Yunyue Chen,

Shuyue Wang, Luhao Zhang

и другие.

Communications Biology, Год журнала: 2025, Номер 8(1)

Опубликована: Март 18, 2025

Precise regulation of protein abundance is critical for cellular homeostasis, whose dysfunction may directly lead to human diseases. Optogenetics allows rapid and reversible control precisely defined processes, which has the potential be utilized dynamics at various scales. Here, we developed a novel optogenetics-based degradation system, namely Peptide-mediated OptoTrim-Away (POT) employs expressed small peptides effectively target endogenous unmodified proteins. By engineering light-induced oligomerization E3 ligase TRIM21, POT can rapidly trigger via proteasomal pathway. Our results showed that POT-PI3K POT-GPX4 modules, used iSH2 FUNDC1 domains specifically phosphoinositide 3-kinase (PI3K) glutathione peroxidase 4 (GPX4) respectively, were able potently induce these proteins by light. Both live-cell imaging biochemical experiments validated potency tools in downregulating cancer cell migration, proliferation, even promotion apoptosis. Therefore, believe offers an alternative practical solution manipulation levels, it could potentially employed dissect complex signaling pathways targeted therapies. controllable abundance, providing insights into intricate biological

Язык: Английский

Процитировано

0

Designed peptide binders and nanobodies as PROTAC starting points for targeted degradation of PCNA and BCL6 DOI
Shuai Zhao,

Jingwen Luo,

Pingping Xu

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 142667 - 142667

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

A No-Brainer! The Therapeutic Potential of TRIM Proteins in Viral and Central Nervous System Diseases DOI Creative Commons
Adam Hage,

Marianne Janes,

Sonja M. Best

и другие.

Viruses, Год журнала: 2025, Номер 17(4), С. 562 - 562

Опубликована: Апрель 14, 2025

Tripartite motif (TRIM) proteins comprise an important class of E3 ubiquitin ligases that regulate numerous biological processes including protein expression, cellular signaling pathways, and innate immunity. This ubiquitous participation in fundamental aspects biology has made TRIM a focus study many fields illuminated the negative impact they exert when functioning improperly. Disruption function been linked to success various pathogens separately occurrence development several neurodegenerative diseases, making appealing candidate for novel therapeutic approaches. Here, we review current findings on demonstrate their analogous properties distinct viral infection central nervous system (CNS) disorders. We also examine recent advancements drug targeted degradation as potential strategies TRIM-mediated treatments discuss implications these technologies have future research directions.

Язык: Английский

Процитировано

0

A Nanobody-based TRIM-away targets the intracellular protein degradation of African Swine Fever Virus DOI
Fayu Yang,

Yuxi Yang,

Xiaoyun Li

и другие.

Virology, Год журнала: 2024, Номер 600, С. 110283 - 110283

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

2

Human-derived monoclonal autoantibodies as interrogators of cellular proteotypes in the brain DOI Creative Commons
Matthew L. Baum, Christopher M. Bartley

Trends in Neurosciences, Год журнала: 2024, Номер unknown

Опубликована: Сен. 1, 2024

Язык: Английский

Процитировано

0